Optimizing the Use of Morphine in Pre-Term Neonates

PHASE2CompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

May 31, 2005

Primary Completion Date

November 30, 2014

Study Completion Date

November 30, 2015

Conditions
Premature Neonates
Interventions
DRUG

Morphine

Gestational Age\< 29 weeks: A loading dose of 0.05 mg/kg I.V. morphine over 30-minutes, followed by a continuous infusion of 0.005 mg/kg/h.

DRUG

Morphine

Gestational Age\>= 29 weeks: A loading dose of 0.1 mg/kg I.V. morphine over 30-minutes, followed by a continuous infusion of 0.01 mg/kg/h.

Trial Locations (1)

20010

Children's National Medical Center, Washington D.C.

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

University of Louisville

OTHER

collaborator

Erasmus Medical Center

OTHER

lead

John van den Anker

OTHER